Real-world safety and effectiveness of lurasidone in Chinese children and adolescents with schizophrenia: Findings from a prospective cohort

Table 3 Adverse events during surveillance, n (%)

Adverse events	Pediatric	Cases	Adult	Cases
Investigations	4 (2.9)	4	38 (2.9)	39
Weight gain	4 (2.9)	4	24 (1.8)	24
Prolactin elevation			10 (0.8)	10
Triglyceride elevation			2 (0.2)	2
Neurological disorders	2 (1.4)	2	9 (0.7)	10
Akathisia			5 (0.4)	5
Drowsiness	2 (1.4)	2	3 (0.2)	3
Gastrointestinal disorders			4 (0.3)	4
Nausea			4	4
Total	6 (4.3)	6	54 (4.1)	61